Senior Principal Scientist
Genentech, Inc.
South San Francisco, California
Bob Liu Bio:
Currently, I am a Sr. Principal Scientist in the Department of Bioanalytical Sciences in Genentech/Roche, where I have been for the past three years. My primary focus is on the development and implementation of clinical assays to monitor immunogenicity for T cell bispecifics (TCB) and allogeneic CAR-T therapies. With 13 years of experience supporting drug development across various companies, including Cytomx, Amunix, Cellerant, and Stemcentrx, I have led and contributed to oncology programs utilizing diverse therapeutic modalities, such as CAR-T, TCB, and antibody-drug conjugates (ADC). My passion lies in advancing drug development across all stages, from early discovery to late clinical trials.
Disclosure information not submitted.
Fit-for-purpose Approaches to Support Immunogenicity Assessment of Multivalent Bispecific Antibodies
Wednesday, July 16, 2025
8:55 AM - 9:20 AM ET
Building for Change: Technologies, Modalities: Panel Discussion
Wednesday, July 16, 2025
11:10 AM - 11:55 AM ET